ID26809A - Senyawa-senyawa turunan sianoiminokuinoksalin - Google Patents

Senyawa-senyawa turunan sianoiminokuinoksalin

Info

Publication number
ID26809A
ID26809A IDW20002390A ID20002390A ID26809A ID 26809 A ID26809 A ID 26809A ID W20002390 A IDW20002390 A ID W20002390A ID 20002390 A ID20002390 A ID 20002390A ID 26809 A ID26809 A ID 26809A
Authority
ID
Indonesia
Prior art keywords
sianoiminokuinoksalin
compounds
compound
ncn
independently
Prior art date
Application number
IDW20002390A
Other languages
English (en)
Indonesian (id)
Inventor
Susumu Takada
Nobuo Chomei
Tsuyoshi Kihara
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of ID26809A publication Critical patent/ID26809A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20002390A 1998-06-01 1999-05-28 Senyawa-senyawa turunan sianoiminokuinoksalin ID26809A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15101798 1998-06-01

Publications (1)

Publication Number Publication Date
ID26809A true ID26809A (id) 2001-02-08

Family

ID=15509486

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002390A ID26809A (id) 1998-06-01 1999-05-28 Senyawa-senyawa turunan sianoiminokuinoksalin

Country Status (20)

Country Link
US (1) US6525054B1 (pt)
EP (1) EP1097927B1 (pt)
JP (1) JP3231338B2 (pt)
KR (1) KR20010043981A (pt)
CN (1) CN1304404A (pt)
AT (1) ATE333447T1 (pt)
AU (1) AU744274B2 (pt)
BR (1) BR9910859A (pt)
CA (1) CA2333515A1 (pt)
DE (1) DE69932441T2 (pt)
HU (1) HUP0102854A3 (pt)
ID (1) ID26809A (pt)
IL (1) IL139783A0 (pt)
NO (1) NO20006065L (pt)
NZ (1) NZ508280A (pt)
PL (1) PL344406A1 (pt)
RU (1) RU2217426C2 (pt)
TR (1) TR200003572T2 (pt)
WO (1) WO1999062887A1 (pt)
ZA (1) ZA200006838B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100581344B1 (ko) * 2003-05-02 2006-05-23 주식회사디엔에이링크 텔로머라제 활성 억제용 조성물
EP2241557A1 (de) 2009-04-02 2010-10-20 Æterna Zentaris GmbH Chinoxalin-Derivate und deren Anwendung zur Behandlung gutartiger und bösartiger Tumorerkrankungen
CN104177595A (zh) * 2013-05-28 2014-12-03 海洋王照明科技股份有限公司 含喹喔啉基的聚合物及其制备方法和有机太阳能电池器件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369057B1 (en) 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
AU688459B2 (en) 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
CA2199468C (en) * 1994-09-27 2006-06-06 Jun-Ichi Shishikura 1,2,3,4-tetrahydroquinoxalinedione derivative
HUT76302A (en) 1995-11-30 1997-07-28 Chinoin Gyogyszer Es Vegyeszet Quinoxaline derivatives, pharmaceutical compositions containing them and process for producing them
AUPN842196A0 (en) 1996-03-05 1996-03-28 Fujisawa Pharmaceutical Co., Ltd. New compound
JP2000506170A (ja) * 1996-03-05 2000-05-23 メデイノックス,インコーポレイテッド 酸化窒素スキャベンジャーを用いる複合治療方法とそのために有用な組成物

Also Published As

Publication number Publication date
EP1097927A1 (en) 2001-05-09
WO1999062887A1 (en) 1999-12-09
NO20006065D0 (no) 2000-11-29
NO20006065L (no) 2001-01-31
AU3955399A (en) 1999-12-20
ATE333447T1 (de) 2006-08-15
US6525054B1 (en) 2003-02-25
DE69932441D1 (de) 2006-08-31
HUP0102854A3 (en) 2002-07-29
AU744274B2 (en) 2002-02-21
JP3231338B2 (ja) 2001-11-19
DE69932441T2 (de) 2007-03-15
NZ508280A (en) 2002-09-27
IL139783A0 (en) 2002-02-10
CN1304404A (zh) 2001-07-18
ZA200006838B (en) 2001-05-23
HUP0102854A2 (hu) 2002-03-28
PL344406A1 (en) 2001-11-05
TR200003572T2 (tr) 2001-06-21
EP1097927B1 (en) 2006-07-19
RU2217426C2 (ru) 2003-11-27
CA2333515A1 (en) 1999-12-09
BR9910859A (pt) 2001-03-13
EP1097927A4 (en) 2002-08-07
KR20010043981A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
ATE180468T1 (de) Anthranilsäure derivate
DE69519469D1 (de) Chinazolin-derivate
BR9910621A (pt) Novos compostos de imidazol 2-alquil substituìdos
ID23954A (id) Tetrahidrogama-karbolin
DE69824450D1 (de) Biphenylamidin-derivate
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
ATE246686T1 (de) Pyrrolocarbazolderivate
ID26809A (id) Senyawa-senyawa turunan sianoiminokuinoksalin
DE69621506T2 (de) Substituierte Aminochinazolinon (thion) Derivate und deren Sälze, deren Zwischenprodukten und Pestkontrollemittel und deren Verwendungsmittel
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
FI822706A0 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva heteroaryloxipropanolaminer